Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness transient, Photopsia, Vitreous floaters
Clinical narrative: Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision; Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision; Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision; This spontaneous case was reported by a patient and describes the occurrence of BLINDNESS TRANSIENT (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibroids. Previously administered products included for Product used for unknown indication: Flu shot on 07-Oct-2021. Past adverse reactions to the above products included No adverse event with Flu shot.    On 15-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced BLINDNESS TRANSIENT (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision) (seriousness criterion medically significant), VITREOUS FLOATERS (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision) and PHOTOPSIA (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision). At the time of the report, BLINDNESS TRANSIENT (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision), VITREOUS FLOATERS (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision) and PHOTOPSIA (Having issues with my eyes/ vision shortly after getting the vaccine. Flashing, floaters, brief periods of no vision) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use), the reporter did not provide any causality assessments.   No concomitant medications was provided. It was unknown if the patient experienced any additional symptoms or events. Patient had no lab data or results available. No treatment medications was provided.  Company comment:  This is a spontaneous case concerning a 57-year-old, female patient with no relevant medical history reported, who experienced the unexpected serious (medically significant) event of Blindness transient and non-serious events of Vitreous floaters and Photopsia. The events occurred after the administration of an unknown dose of mRNA-1273 vaccine. Latency could not be assessed due to lack of information of onset date. Outcome reported as not recovered. No further information on clinical course, investigations and treatment received was available in the report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.